Since its establishment in 1956, Albion has been an innovator in mineral chelate nutrition. Albion manufactures highly bioavailable nutritional mineral forms and has a long-standing customer base in both the beef and dairy markets.
Geographically, Albion is primarily present in the animal organic trace mineral industry in the US, Europe, the Middle East and Japan.
The combined geographic and market presence will provide Novus the opportunity to offer new customers a wide range of health through nutritional products, programs, and solutions.
Products from the acquisition will align with Novus’s Mintrex® chelated trace mineral products and further expand its mineral technology.
When complete, this acquisition will enable
Novus to offer its customers and the animal agriculture market an expanded chelated trace mineral product portfolio to support their livestock operations.
“The intent to acquire Albion’s animal division is consistent with the direction Novus has taken to work with industry partners to achieve greater production efficiencies and minimize environmental impact,” said Giovanni Gasperoni, Executive Vice President, Novus International.
“Novus will continue to fully support and invest in its chelated trace mineral technology. Albion will be viewed as an additional line to support the industry’s movement to superior, well-defined and efficacious chelated mineral solutions.”